Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Pharmacology and Obesity Treatment, Bariatric Surgery and Outcomes, and Lipoproteins and Cardiovascular Health.
Mazdutide versus placebo in Chinese adults with type 2 diabetes
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial